Autologous transplantation for multiple myeloma.

Trial Profile

Autologous transplantation for multiple myeloma.

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Melphalan (Primary) ; Cyclophosphamide; Granulocyte colony-stimulating factors
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
    • 12 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
    • 12 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top